Sensei Biotherapeutics Files 8-K on Financials
Ticker: SNSE · Form: 8-K · Filed: May 6, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Sensei Biotherapeutics filed an 8-K on May 6, 2025, updating investors on their financial condition and results.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, but does not detail specific financial figures or operational outcomes within the provided text.
Why It Matters
This filing provides an update on Sensei Biotherapeutics' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting financial condition and results, with no immediate negative or positive events indicated in the provided text.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- May 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39980 (identifier) — Commission File Number
- 1405 Research Blvd, Suite 125 (address) — Principal Executive Offices
- Rockville, MD 20850 (address) — Principal Executive Offices Location
- (240) 243-8000 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported by Sensei Biotherapeutics?
The filing indicates it reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific figures are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated May 6, 2025.
What is Sensei Biotherapeutics' state of incorporation?
Sensei Biotherapeutics, Inc. is incorporated in Delaware.
Where are Sensei Biotherapeutics' principal executive offices located?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the purpose of this 8-K filing?
This 8-K filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the company's results of operations and financial condition.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).